Clinical Trial Update: Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trials are evaluating clascoterone for steroid-related acne vulgaris in transgender men receiving masculinizing hormone therapy; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• clascoterone (clascoterone)

Snippet

Sponsor: Stanford University | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: RECRUITING